PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Sep 2, 2026, 2:19 AM

Roche signs global licensing pact for Simcere's experimental blood cancer drug

Simcere is also ⁠eligible to receive up to ​about $1.46 billion in payments for unspecified ​milestones.

Pharma Tech

Sep 1, 2026, 6:53 PM

ESC 2026: Tirzepatide 5mg sustains cardiometabolic benefit with weight maintenance

KOLs interviewed by GlobalData consistently recognized tirzepatide's cardiometabolic value as extending well beyond weight loss alone.

Pharma Tech

Sep 1, 2026, 1:59 PM

Why CMC readiness is becoming central to biopharma licensing deals

CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied

PharmaShots

Sep 1, 2026, 12:30 PM

CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange system

Shots: Ref: Cortec  | Image: Cortec   |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange system appeared first on PharmaShots.

PharmaShots

Sep 1, 2026, 12:30 PM

Key Biosimilars Events of August 2026 

Shots:                 Company: Biocon                 Product: Yesafili                 Active Ingredient: Aflibercept                 Reference Product: Eylea                 Reference Product Company: Bayer                 Disease: All Approved Indications                 Date: Aug 03, 2026                 Shots:                 Company: Fresenius Kabi & Dr Reddy’s Laboratories                 Product: Rituximab                 Active Ingredient: Rituximab                 Reference Product: Rituxan                  Reference Product Company: Genentech & Biogen                 Disease: All Approved Indications                 Date: Aug 03, 2026                 Shots:                  Company: Samsung Bioepis                 Product: Opuviz                 Active Ingredient: Aflibercept                 Reference Product: Eylea                 Reference Product Company: Bayer                 Disease: All Approved Indications                 Date: Aug 10, 2026                 Shots: … The post Key Biosimilars Events of August 2026  appeared first on PharmaShots.

ET Pharma

Sep 1, 2026, 12:16 PM

Cipla licenses cancer bispecific from China’s Sino Biopharma

Under the agreement, the chinese drugmaker is entitled to receive up to $123 million in upfront, development and regulatory milestone along with double-digit royalties on annual sales.

News

Latest industry coverage

Google News

Sep 2, 2026, 4:24 AM

For SK Biopharm, the Next Drug Discovery Lab Is Packed With GPUs - Koreabizwire

For SK Biopharm, the Next Drug Discovery Lab Is Packed With GPUs  Koreabizwire

Google News

Sep 2, 2026, 3:25 AM

Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued? - simplywall.st

Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued?  simplywall.st

Google News

Sep 1, 2026, 11:21 PM

Employees rise with yeast, biotech giant - chinadaily.com.cn

Employees rise with yeast, biotech giant  chinadaily.com.cn

Google News

Sep 1, 2026, 10:44 PM

Novartis MS pill beats older drug in trials, boosts pipeline hopes - Reuters

Novartis MS pill beats older drug in trials, boosts pipeline hopes  Reuters

Google News

Sep 1, 2026, 10:44 PM

Sun Pharma offers US cheaper drug supply - The Times of India

Sun Pharma offers US cheaper drug supply  The Times of India

Google News

Sep 1, 2026, 9:36 PM

TraceIQ Launched to Maximize Pharmaceutical Traceability - Genetic Engineering and Biotechnology News

TraceIQ Launched to Maximize Pharmaceutical Traceability  Genetic Engineering and Biotechnology News

Google News

Sep 1, 2026, 9:00 PM

Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award - Yahoo! Finance Canada

Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award  Yahoo! Finance Canada

Google News

Sep 1, 2026, 8:55 PM

Nine drugmakers join US most-favored-nation plan - BioXconomy

Nine drugmakers join US most-favored-nation plan  BioXconomy

Google News

Sep 1, 2026, 8:55 PM

Nasus Pharma (NYSE: NSRX) sets $50M share shelf for working capital and drug development - Stock Titan

Nasus Pharma (NYSE: NSRX) sets $50M share shelf for working capital and drug development  Stock Titan

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer